BRT offers human whole blood, PBMC, and other cell-based assays to evaluate immune function and immunomodulatory responses across customized in vitro research programs.
BRT offers in vitro approaches to evaluate cytokine and chemokine responses using human whole blood, PBMC, and other cell-based systems.
BRT offers cell-based assays to evaluate T-cell and natural killer (NK) cell function as part of customized immune function assessments.
BRT offers in vitro assays to evaluate macrophage and neutrophil function as part of customized immune function assessments.
BRT offers additional cell-based assessments to characterize immune cell populations and bone marrow responses within customized immune function studies.
BRT’s in vitro immune function capabilities can be combined across multiple assay types to support customized evaluation of immune responses and immunomodulatory effects.
We work with clients to develop customized in vitro immune function studies based on specific research objectives, test articles, assay systems, and immune response endpoints.
